BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11201673)

  • 1. An approach to cancer risk assessment for the food constituent 2-hexenal on the basis of 1,N2-propanodeoxyguanosine adducts of 2-hexenal in vivo.
    Eder E; Schuler D
    Arch Toxicol; 2000 Dec; 74(10):642-8. PubMed ID: 11201673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of 1,N2-propanodeoxyguanosine adducts of 2-hexenal in organs of Fischer 344 rats by a 32P-post-labeling technique.
    Schuler D; Eder E
    Carcinogenesis; 1999 Jul; 20(7):1345-50. PubMed ID: 10383910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach.
    Eder E; Schuler D; Budiawan
    IARC Sci Publ; 1999; (150):219-32. PubMed ID: 10626223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a 32P-postlabelling method for the detection of 1,N2-propanodeoxyguanosine adducts of crotonaldehyde in vivo.
    Schuler BD; Eder E
    Arch Toxicol; 2000 Sep; 74(7):404-14. PubMed ID: 11043496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a 32P-postlabeling method for the detection of 1, N2-propanodeoxyguanosine adducts of 2-hexenal in vivo.
    Schuler D; Budiawan B; Eder E
    Chem Res Toxicol; 1999 Apr; 12(4):335-40. PubMed ID: 10207122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (E)-2-hexenal-induced DNA damage and formation of cyclic 1,N2-(1,3-propano)-2'-deoxyguanosine adducts in mammalian cells.
    Gölzer P; Janzowski C; Pool-Zobel BL; Eisenbrand G
    Chem Res Toxicol; 1996; 9(7):1207-13. PubMed ID: 8902278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of 1,N2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal after gavage of trans-4-hydroxy-2-nonenal or induction of lipid peroxidation with carbon tetrachloride in F344 rats.
    Wacker M; Wanek P; Eder E
    Chem Biol Interact; 2001 Sep; 137(3):269-83. PubMed ID: 11566294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer risk assessment for the environmental mutagen and carcinogen crotonaldehyde on the basis of TD(50) and comparison with 1,N(2)-propanodeoxyguanosine adduct levels.
    Eder E; Budiawan
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):883-8. PubMed ID: 11489755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of 1, N2-propanodeoxyguanosine adducts as potential endogenous DNA lesions in rodent and human tissues.
    Nath RG; Ocando JE; Chung FL
    Cancer Res; 1996 Feb; 56(3):452-6. PubMed ID: 8564951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a (32)P-postlabeling method for the detection of 1,N(2)-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in vivo.
    Wacker M; Schuler D; Wanek P; Eder E
    Chem Res Toxicol; 2000 Nov; 13(11):1165-73. PubMed ID: 11087439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of cyclic 1,N2-propanodeoxyguanosine adducts in DNA of rats treated with N-nitrosopyrrolidine and mice treated with crotonaldehyde.
    Chung FL; Young R; Hecht SS
    Carcinogenesis; 1989 Jul; 10(7):1291-7. PubMed ID: 2736720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of 1,N(2)-propanodeoxyguanosine adducts in DNA of Fischer 344 rats by an adapted (32)P-post-labeling technique after per os application of crotonaldehyde.
    Budiawan ; Eder E
    Carcinogenesis; 2000 Jun; 21(6):1191-6. PubMed ID: 10837009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the tumor-initiating potential of alpha, beta-unsaturated carbonyl compounds by 32P postlabeling quantification of DNA adducts in vivo.
    Eder E; Budiawan ; Schuler D; Otteneder M
    Recent Results Cancer Res; 1997; 143():65-75. PubMed ID: 8912412
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxicity, DNA binding, and cell proliferation in male F344 rats following short-term gavage exposures to trans-2-hexenal.
    Stout MD; Bodes E; Schoonhoven R; Upton PB; Travlos GS; Swenberg JA
    Toxicol Pathol; 2008 Feb; 36(2):232-46. PubMed ID: 18362197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA adducts from N-nitrosodiethanolamine and related beta-oxidized nitrosamines in vivo: (32)P-postlabeling methods for glyoxal- and O(6)-hydroxyethyldeoxyguanosine adducts.
    Loeppky RN; Ye Q; Goelzer P; Chen Y
    Chem Res Toxicol; 2002 Apr; 15(4):470-82. PubMed ID: 11952332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of immunoaffinity chromatography enrichment and nuclease P1 procedures for 32P-postlabelling analysis of PAH-DNA adducts.
    Randerath K; Sriram P; Moorthy B; Aston JP; Baan RA; van den Berg PT; Booth ED; Watson WP
    Chem Biol Interact; 1998 Mar; 110(1-2):85-102. PubMed ID: 9566727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 32P-postlabeling method for simultaneous detection and quantification of exocyclic etheno and propano adducts in DNA.
    Nath RG; Chen HJ; Nishikawa A; Young-Sciame R; Chung FL
    Carcinogenesis; 1994 May; 15(5):979-84. PubMed ID: 8200104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A physiologically based in silico model for trans-2-hexenal detoxification and DNA adduct formation in rat.
    Kiwamoto R; Rietjens IM; Punt A
    Chem Res Toxicol; 2012 Dec; 25(12):2630-41. PubMed ID: 22978292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An HPLC-EC assay for 1,N2-propano adducts of 2'-deoxyguanosine with 4-hydroxynonenal and other alpha,beta-unsaturated aldehydes.
    Douki T; Ames BN
    Chem Res Toxicol; 1994; 7(4):511-8. PubMed ID: 7981415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 32P-postlabeling analysis of adducts generated by peroxidase-mediated binding of N-hydroxy-4-acetylaminobiphenyl to DNA.
    Hatcher JF; Swaminathan S
    Carcinogenesis; 1995 Sep; 16(9):2149-57. PubMed ID: 7554068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.